Treatment of Elderly Chinese Acute Myeloid Leukemia Patients Aged 65 to 75 Years Old
Status:
Unknown status
Trial end date:
2021-05-01
Target enrollment:
Participant gender:
Summary
This study focus on the comparison of CAG regimen to the low dose cytarabine therapy in
elderly AML patients who are unfit or unwilling to receive intensive chemotherapy.